miRNA Details
miRNA General Information | |||||
---|---|---|---|---|---|
miRNA Mature ID | hsa-miR-222-3p | ||||
miRNA Stemloop AC | MI0000299 | ||||
miRNA Stemloop ID | hsa-mir-222 | ||||
Sequence | agcuacaucuggcuacugggu | ||||
TTD Target(s) Regulated by This miRNA | Estrogen receptor (ESR) | Successful Target | Target Info | [1] | |
Matrix metalloproteinase-1 (MMP-1) | Successful Target | Target Info | [2] | ||
Tyrosine-protein kinase Kit (KIT) | Successful Target | Target Info | [3] | ||
ATP-binding cassette transporter G2 (ABCG2) | Successful Target | Target Info | [4] | ||
Intercellular adhesion molecule ICAM-1 (ICAM1) | Successful Target | Target Info | [5] | ||
O-6-methylguanine-DNA-alkyltransferase (MGMT) | Clinical trial Target | Target Info | [6] | ||
Cellular tumor antigen p53 (TP53) | Clinical trial Target | Target Info | [7] | ||
E-selectin (SELE) | Clinical trial Target | Target Info | [5] | ||
Superoxide dismutase Mn (SOD Mn) | Clinical trial Target | Target Info | [8] | ||
TNF related apoptosis inducing ligand (TNFSF10) | Clinical trial Target | Target Info | [9] | ||
Gap junction alpha-1 protein (GJA1) | Clinical trial Target | Target Info | [10] | ||
Phosphatase and tensin homolog (PTEN) | Literature-reported Target | Target Info | [11] | ||
Bcl-2-binding component 3 (BBC3) | Literature-reported Target | Target Info | [12] | ||
Forkhead box protein O1A (FOXO1) | Literature-reported Target | Target Info | [13] | ||
Protein C-ets-1 (ETS1) | Literature-reported Target | Target Info | [14] | ||
Proto-oncogene c-Fos (c-Fos) | Literature-reported Target | Target Info | [15] | ||
AN1-type zinc finger protein 5 (ZFAND5) | Literature-reported Target | Target Info | [16] | ||
CDK inhibitor 1B p27Kip1 (CDKN1B) | Literature-reported Target | Target Info | [17] | ||
Dickkopf-related protein 2 (DKK2) | Literature-reported Target | Target Info | [18] | ||
CDK inhibitor 1C p57Kip2 (CDKN1C) | Literature-reported Target | Target Info | [19] | ||
Runt-related transcription factor 2 (RUNX2) | Literature-reported Target | Target Info | [20] | ||
SSX2-interacting protein (SSX2IP) | Literature-reported Target | Target Info | [21] | ||
Suppressor of tumorigenicity 15 protein (ST15) | Literature-reported Target | Target Info | [22] | ||
Protein(s) Regulated by This miRNA | Acyl-protein thioesterase 1 | Regulated Protein | [16] | ||
Apoptosis-stimulating of p53 protein 2 | Regulated Protein | [16] | |||
AT-rich interactive domain-containing protein 1A | Regulated Protein | [24] | |||
Bcl-2-modifying factor | Regulated Protein | [25] | |||
Ceramide synthase 2 | Regulated Protein | [26] | |||
Coronin-1A | Regulated Protein | [7] | |||
Forkhead box protein O3 | Regulated Protein | [28] | |||
Growth factor receptor-bound protein 10 | Regulated Protein | [29] | |||
GTP-binding protein Di-Ras3 | Regulated Protein | [30] | |||
Guanine nucleotide-binding protein G(i) subunit alpha-2 | Regulated Protein | [31] | |||
Guanine nucleotide-binding protein G(k) subunit alpha | Regulated Protein | [32] | |||
Metalloproteinase inhibitor 3 | Regulated Protein | [33] | |||
Mothers against decapentaplegic homolog 5 | Regulated Protein | [20] | |||
Multiple epidermal growth factor-like domains protein 9 | Regulated Protein | [16] | |||
Phosphatase and actin regulator 4 | Regulated Protein | [16] | |||
Plexin-C1 | Regulated Protein | [25] | |||
PR domain zinc finger protein 1 | Regulated Protein | [35] | |||
Protein FAM214A | Regulated Protein | [16] | |||
Protein mono-ADP-ribosyltransferase TIPARP | Regulated Protein | [16] | |||
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform | Regulated Protein | [36] | |||
Sjoegren syndrome/scleroderma autoantigen 1 | Regulated Protein | [37] | |||
Transcription cofactor vestigial-like protein 4 | Regulated Protein | [38] | |||
Transcription elongation factor A protein-like 1 | Regulated Protein | [7] | |||
Transmembrane emp24 domain-containing protein 7 | Regulated Protein | [7] | |||
Type II inositol 3,4-bisphosphate 4-phosphatase | Regulated Protein | [16] | |||
Uncharacterized protein C18orf25 | Regulated Protein | [16] | |||
Zinc finger transcription factor Trps1 | Regulated Protein | [39] | |||
References | |||||
REF 1 | The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol. 2007 May;21(5):1132-47. | ||||
REF 2 | MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. Cancer Genomics Proteomics. 2009 May-Jun;6(3):131-9. | ||||
REF 3 | MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18081-6. | ||||
REF 4 | Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential. Oncotarget. 2015 Dec 29;6(42):44538-50. | ||||
REF 5 | Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J Immunol. 2010 Jan 1;184(1):21-5. | ||||
REF 6 | MiR-221/222 target the DNA methyltransferase MGMT in glioma cells. PLoS One. 2013 Sep 19;8(9):e74466. | ||||
REF 7 | miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells. J Oral Pathol Med. 2011 Aug;40(7):560-6. | ||||
REF 8 | MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J. 2008 Dec;22(12):4126-35. | ||||
REF 9 | MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene. 2008 Jun 19;27(27):3845-55. | ||||
REF 10 | miR-221/222 is the regulator of Cx43 expression in human glioblastoma cells. Oncol Rep. 2012 May;27(5):1504-10. | ||||
REF 11 | Prediction of mammalian microRNA targets. Cell. 2003 Dec 26;115(7):787-98. | ||||
REF 12 | miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):264-9. | ||||
REF 13 | MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway. Gene. 2017 Jan 5;596:110-118. | ||||
REF 14 | Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis. 2011 Apr;215(2):286-93. | ||||
REF 15 | MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells. Mol Pharmacol. 2010 Jun;77(6):1016-24. | ||||
REF 16 | MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targets. PLoS One. 2012;7(7):e40676. | ||||
REF 17 | miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem. 2007 Aug 10;282(32):23716-24. | ||||
REF 18 | MicroRNA-222 promotes tumorigenesis via targeting DKK2 and activating the Wnt/-catenin signaling pathway. FEBS Lett. 2013 Jun 19;587(12):1742-8. | ||||
REF 19 | MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. Cancer Res. 2008 Apr 15;68(8):2773-80. | ||||
REF 20 | Inhibition of miR-222-3p activity promoted osteogenic differentiation of hBMSCs by regulating Smad5-RUNX2 signal axis. Biochem Biophys Res Commun. 2016 Feb 12;470(3):498-503. | ||||
REF 21 | miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer. PLoS One. 2013 Jun 11;8(6):e66502. | ||||
REF 22 | miR-221 and miR-222 Simultaneously Target RECK and Regulate Growth and Invasion of Gastric Cancer Cells. Med Sci Monit. 2015 Sep 13;21:2718-25. | ||||
REF 23 | MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targets. PLoS One. 2012;7(7):e40676. | ||||
REF 24 | Role and mechanism of miR-222 in arsenic-transformed cells for inducing tumor growth.Oncotarget. 2016 Apr 5;7(14):17805-14. | ||||
REF 25 | Gas5 Exerts Tumor-suppressive Functions in Human Glioma Cells by Targeting miR-222.Mol Ther. 2015 Dec;23(12):1899-911. | ||||
REF 26 | miR-221 and miR-222 promote Schwann cell proliferation and migration by targeting LASS2 after sciatic nerve injury.J Cell Sci. 2012 Jun 1;125(Pt 11):2675-83. | ||||
REF 27 | miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells. J Oral Pathol Med. 2011 Aug;40(7):560-6. | ||||
REF 28 | MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J Natl Cancer Inst. 2010 May 19;102(10):706-21. | ||||
REF 29 | Interactions of Melanoma Cells with Distal Keratinocytes Trigger Metastasis via Notch Signaling Inhibition of MITF. Mol Cell. 2015 Aug 20;59(4):664-76. | ||||
REF 30 | MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer.Cancer Prev Res (Phila). 2011 Jan;4(1):76-86. | ||||
REF 31 | MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.Oncotarget. 2016 Dec 6;7(49):80633-80654. | ||||
REF 32 | GNAI3 inhibits tumor cell migration and invasion and is post-transcriptionally regulated by miR-222 in hepatocellular carcinoma.Cancer Lett. 2015 Jan 28;356(2 Pt B):978-84. | ||||
REF 33 | miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell. 2009 Dec 8;16(6):498-509. | ||||
REF 34 | Inhibition of miR-222-3p activity promoted osteogenic differentiation of hBMSCs by regulating Smad5-RUNX2 signal axis. Biochem Biophys Res Commun. 2016 Feb 12;470(3):498-503. | ||||
REF 35 | Uncovering MicroRNA Regulatory Hubs that Modulate Plasma Cell Differentiation.Sci Rep. 2015 Dec 11;5:17957. | ||||
REF 36 | MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.Clin Cancer Res. 2010 Feb 1;16(3):867-75. | ||||
REF 37 | Long Non-coding RNA Growth Arrest-specific Transcript 5 (GAS5) Inhibits Liver Fibrogenesis through a Mechanism of Competing Endogenous RNA.J Biol Chem. 2015 Nov 20;290(47):28286-98. | ||||
REF 38 | miR-222/VGLL4/YAP-TEAD1 regulatory loop promotes proliferation and invasion of gastric cancer cells. Am J Cancer Res. 2015 Feb 15;5(3):1158-68. | ||||
REF 39 | TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer.Sci Signal. 2011 Jun 14;4(177):ra41. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.